In the present work, we explore the expression profiles of FOXN3 in HCC and describe a biochemical and genetic interaction between FOXN3 and E2F5, which was originally identified based on its ability to act as a tumor suppressor in HCC. The gene discussed is E2F5; the disease is neoplasm.